Imugene is in the box seat here, with a first in class Azer-cel Allogeniec,(off the shelf tratment) in a potential registrational trial to treat failed patients of Autologus Car-t treatment.
Nothing else out there this close and with 84 patients data to prove efficacy it is really just a matter of time.
DYOR opinion only
SPP uptake, page-71
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
-0.002(3.00%) |
Mkt cap ! $360.7M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $192.0K | 3.927M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 54 | 6288587 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 5357333 | 33 |
View Market Depth
| Last trade - 11.57am 03/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |